Milestone Scientific launches new corporate website
Milestone Scientific has developed a new corporate website designed to clarify and better convey Milestone’s key messaging and current business information. The site will also
Milestone Scientific has developed a new corporate website designed to clarify and better convey Milestone’s key messaging and current business information. The site will also
A U.S. Senate committee on July 29 approved a provision meant to inhibit branded drug companies from delaying the introduction of generic versions of their
Conscious sedation is growing in popularity in Australia, but dental experts warn some dentists may be putting patients at risk by using the technique without
The U.S. Federal Trade Commission (FTC) is trying to stop drug companies from paying each other not to introduce competing products, according to commission Chairman
A California dentist convicted of killing three patients by giving them fatal doses of anesthesia has been granted parole, according to news stories. Tony Protopappas
Pharmacologic management can be used to treat trigeminal nerve injury pain after dental implant surgery, according to a study in the International Journal of Prosthodontics
Paresthesia occurs more often after use of 4% local anesthetic formulations, according to a study in the Journal of the American Dental Association (July 2010,
Merck has been ordered to pay $8 million in compensatory damages to a 72-year-old woman who claimed the company’s bisphosphonate drug Fosamax caused her to
Dental Optimizer, a free online oral health application, now features a pharmacy module designed to allow patients to find out if the medications they are
Lidocaine, when administered via nose drops or a nasal spray, travels through the trigeminal nerve and collects in high concentrations in the teeth, jaw, and
When children and adults with acute and chronic pain become immersed in video game action, they receive some analgesic benefit, according to research presented May
A federal court jury in New York has found in favor of Merck in the second trial involving the pharmaceutical company’s Fosamax bisphosphonate drug. The